Compare · CON vs ELV
CON vs ELV
Side-by-side comparison of Concentra Group Holdings Parent Inc. (CON) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CON and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $86.50B, about 19.5x CON ($4.44B).
- CON has hit the wire 10 times in the past 4 weeks while ELV has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 13 for CON).
- Company
- Concentra Group Holdings Parent Inc.
- Elevance Health Inc.
- Price
- -
- -
- Market cap
- $4.44B
- $86.50B
- 1M return
- +8.93%
- -
- 1Y return
- +52.10%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 10
- 0
- Recent ratings
- 13
- 23
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CON
- Director Ortenzio Robert A returned $34,680,000 worth of shares to the company (1,000,000 units at $34.68), decreasing direct ownership by 14% to 4,763,794 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Concentra Group Holdings Parent Inc.
- Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health
- Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition
- Concentra to Present at Upcoming Investor Conferences
- SEC Form 10-Q filed by Concentra Group Holdings Parent Inc.
- Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance
- Director Ortenzio Robert A sold $4,139,356 worth of shares (130,000 units at $31.84) (SEC Form 4)
- SEC Form 144 filed by Concentra Group Holdings Parent Inc.
Latest ELV
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS